- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, October 9, 2020
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
A piece posted on Newswire cited an article published on AJMC.com, the website of The American Journal of Managed Care® (AJMC®). The article, “How Has COVID-19 Affected Mental Health, Severity of Stress Among Employees,” examined findings from a study by mental health provider Ginger, in which nearly 7 in 10 employees indicated that the coronavirus disease 2019 (COVID-19) pandemic has been the most stressful time of their entire professional career, which align with stark increases in new prescriptions of antidepressant, antianxiety, and anti-insomnia medications.
An opinion article published by the Chattanooga Times Free Press referenced a study published in the January 2017 issue of AJMC®. The study, “Value-Based Contracting Innovated Medicare Advantage Healthcare Delivery and Improved Survival,” found that elderly Medicare Advantage members with multiple chronic conditions attained a survival benefit from more cost-effective care when a private plan developed gainshare and monetary risk-bearing arrangements with its contracted providers.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
